Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism-Reference-Cited by-同舟云学术

Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism

Published:2016-02 Issue:2 Volume:1 Page:172-179
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Laborde Julie¹²,Deraeve Céline¹²,Lecoq Léa¹²,Sournia-Saquet Alix¹²,Stigliani Jean-Luc¹²,Orena Beatrice S.³,Mori Giorgia³,Pratviel Geneviève¹²,Bernardes-Génisson Vania¹²

Affiliation:

1. CNRS; LCC (Laboratoire de Chimie de Coordination), 205; route de Narbonne, BP 44099 F-31077 Toulouse, Cedex 4 France

2. Université de Toulouse; UPS, INPT; F-31077 Toulouse, Cedex 4 France

3. University of Pavia; Dipartimento di Biologia e Biotecnologie “Lazzaro Spallanzani”; via Ferrata 1 27100 Pavia Italy

Publisher

Wiley

Subject

General Chemistry

Reference34 articles.

1. Bedaquiline: First FDA-approved tuberculosis drug in 40 years

2. Isoniazid: an Update on the Multiple Mechanisms for a Singular Action

3. Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products;Current Topics in Medicinal Chemistry;2024-06

2. Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update;Drug Development Research;2023-04-21

3. Targeting mycobacterial membranes and membrane proteins: Progress and limitations;Bioorganic & Medicinal Chemistry;2023-03

4. TargetingMycobacterium tuberculosisiron-scavenging tools: a recent update on siderophores inhibitors;RSC Medicinal Chemistry;2023

5. Emerging impact of triazoles as anti-tubercular agent;European Journal of Medicinal Chemistry;2022-08